1. X
  2. @Optellum
Log inSign up
@Optellum
199 posts
Image
user avatar
@Optellum
@Optellum
We are a lung health company, providing artificial intelligence software for clinicians to make the best decisions for early diagnosis and optimal treatment.
Oxford, England
optellum.com
Joined September 2017
271
Following
327
Followers
RepliesRepliesMediaMedia
  • user avatar
    @Optellum
    @Optellum
    Dec 8, 2023
    Is Artificial Intelligence reimbursable? How the value of a new technology is determined and claims assessed Read more in our latest opinion piece by Director of Market Access Carrie Hart. optellum.com/2023/12/is-art…
  • user avatar
    @Optellum
    @Optellum
    Nov 10, 2023
    Lung Cancer Awareness Month is a poignant reminder of the urgent need to spotlight one of the most prevalent and deadliest forms of cancer worldwide. Find out more about our innovative solution here optellum.com/2023/11/lung-c…
  • user avatar
    @Optellum
    @Optellum
    Aug 1, 2023
    Lung cancer is the #1 cancer killer. This #worldlungcancerday we're launching our new video showing how Optellum can help clinicians with the only AI-based lung cancer clinical solution for early diagnosis.​​​​​​ youtu.be/Bxuzs44C68s?si…
  • user avatar
    @Optellum
    @Optellum
    Aug 1, 2023
    Optellum's vision is to redefine early intervention of lung cancer, enabling every clinician, in every hospital, to make the right decisions and give patients the best chance to fight back. #WorldLungCancerDay
    Image
  • user avatar
    @Optellum
    @Optellum
    Jun 22, 2023
    It's time to get serious about incidental lung cancer detection. Optellum's Ryan Hennen speaks to @healthitanswers about challenges in care pathways from broken workflows to low ROI and how the cost-benefit equation is changing. healthitanswers.net/its-time-to-ge… #lungcancer #aiinmedicine
    Image
    It’s Time to Get Serious About Incidental Lung Cancer Detection - Health IT Answers
    From healthitanswers.net

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Advertisement
Advertisement